This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 04/10/2023
Location: Atlanta, GA
Subject: Rx and Illicit Drug Summit
FDA Participant/Group: MARTA SOKOLOWSKA; CAROLINE HUANG; LAUREN-JEI MCCARTHY;
Non FDA Participant/Group: Government, academia, industry, media, and other registered guests

Event Date: 04/12/2023
Location: Silver Spring, MD
Subject: Accelerated Approval Pathway for Ultra-Rare Diseases
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives of Ultragenyx

Event Date: 04/14/2023
Location: New York, NY
Subject: HEVER 28
FDA Participant/Group: NAMANDJE BUMPUS;
Non FDA Participant/Group: Government, industry, and other invited guests

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

Event Date: 04/13/2023
Location: Silver Spring, MD
Subject: America's Got Regulatory Science Talent Competition - Winners Presentations at FDA; Speaker
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Academia, media, and other stakeholders

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 04/12/2023
Location: Virtual
Subject: American Biomanufacturing Summit; Bridging the Gap Between Industry and the FDA to Support Biologics Innovation
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of American Biomanufacturing Summit

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 04/11/2023
Location: Washington, DC
Subject: American Enterprise Institute’s Panel: Medical Device Regulation and Artificial Intelligence: Live Long and Prosper
FDA Participant/Group: N/A
Non FDA Participant/Group: Brian Miller, (American Enterprise Institute), Jesse Ehrenfeld, (Medical College of Wisconsin), members of industry, government, academia, and other stakeholders

Event Date: 04/11/2023
Location: Silver Spring, MD
Subject: Olympus Chief Executive Officer Introductory Meeting
FDA Participant/Group: KEISHA THOMAS; COURTNEY LIAS; WILLIAM MAISEL;
Non FDA Participant/Group: Aaron Dunbar, Stefan Kaufmann, Todd Brill (Olympus Corporation); Pierre Boisier (Olumbus Corporation);

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 04/11/2023
Location: Virtual
Subject: Proposed Rule Tribal Consultation on New Requirements for Tobacco Product Manufacturing Practices (TPMP)
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from tribal governments

Event Date: 04/12/2023
Location: Virtual
Subject: Public Oral Hearing on Proposed New Requirements for Tobacco Product Manufacturing Practices (TPMP)
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from industry and public health stakeholders

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

Event Date: 04/10/2023
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: MATTHEW LUCIA; WILLIAM FLYNN; ROSEMARY EARLEY; TIMOTHY SCHELL; ROXANNE SCHWEITZER;
Non FDA Participant/Group: Representatives of Boehringer Ingelheim Animal Health

Event Date: 04/10/2023
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: WILLIAM FLYNN;
Non FDA Participant/Group: Representatives of Alliance for a Stronger FDA

Event Date: 04/12/2023
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives of Elanco

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event